Dermot McGinnity

Dermot McGinnity has extensive work experience in the field of drug discovery and development. Dermot is currently the Executive Vice President and Head of Global Discovery DMPK at Evotec. Prior to this, they worked at AstraZeneca for several years, where they held various roles such as Executive Director and Senior Director, leading the DMPK teams in oncology R&D and drug safety and metabolism. Before joining AstraZeneca, they held senior positions at AstraZeneca R&D, including Senior Director of DMPK and Head of ADME function. Dermot also has experience from their time at the University of Michigan, where they worked as a Post-doctoral Research Associate.

Dermot McGinnity attended The University of Edinburgh from 1988 to 1995, where they obtained a BSc. and PhD in Biochemistry.